<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>ALTACAINE- tetracaine hydrochlorideÂ solutionÂ </strong><br>Altaire Pharmaceuticals Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>
<span class="Bold">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% Sterile <br></span>Rx Only</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_ed27accd-9442-4768-9e12-1f735b8d3384"></a><a name="section-1"></a><p></p>
<h1><span class="Bold">DESCRIPTION:</span></h1>
<p class="First">Tetracaine Hydrochloride 0.5% is a sterile topical ophthalmic solution useful in producing surface anesthesia of the eye. The active ingredient is represented by the structural formula:</p>
<div class="Figure"><img alt="The structural formula for Tetracaine Hydrochloride." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fd57efaa-9129-47e0-8d47-191e0adb620e&amp;name=tetracaine-hydrochloride-ophthalmic-solution-usp-0-1.jpg"></div>
<p><span class="Bold">Established Name:<br></span>Tetracaine Hydrochloride </p>
<p><span class="Bold">Chemical Name:<br></span>Benzoic acid, 4-(butylamino)-,2-(dimethylamino)ethyl ester, monohydrochloride </p>
<p><span class="Bold">CONTAINS:<br></span><span class="Bold">Active:</span> Tetracaine Hydrochloride 0.5%; <span class="Bold">Preservative: </span>Chlorobutanol; <span class="Bold">Inactive: </span>Boric Acid, Edetate Disodium, Potassium Chloride, Water for Injection, USP, Hydrochloric Acid and/or Sodium Hydroxide to adjust pH.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_9912ee73-0257-405d-8002-5908868e75b2"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY:</span></h1>
<p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% acts by decreasing the permeability of the neuronal membrane, thereby decreasing the flux of sodium, potassium and other ions associated with propagation of the nerve impulse. The onset of anesthesia usually begins within 30 seconds and lasts a relatively short period of time. </p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_5d9b84e6-6e88-4b48-b84b-6698090ebd3a"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">For procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy, removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva, other short corneal and conjunctival procedures.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_fb8860f4-bb1b-48e0-80fd-128c46ea6e51"></a><a name="section-4"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS:</span></h1>
<p class="First">Should not be used by the patient without physician supervision, or in those persons showing <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component of this preparation. </p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_87465bb2-b0a0-4229-8faa-ec9656c60aef"></a><a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First">For topical ophthalmic use only. Not for parenteral use. Not for injection. Do not use solution if it contains crystals or if it is cloudy or discolored. Prolonged use results in diminished duration of anesthesia and retarded healing. This may cause the drug to be used more frequently, creating a Â â€œvicious circleâ€?. Subsequent <span class="product-label-link" type="condition" conceptid="4208814" conceptname="Corneal infection">corneal infection</span> and/or corneal opacification with accompanying permanent visual loss or <span class="product-label-link" type="condition" conceptid="4326414" conceptname="Perforation of cornea">corneal perforation</span> may occur. Prolonged use may also produce severe <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>. </p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_bae974d6-4890-4c19-abd2-8c1bc3d77a1b"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="LINK_31822ede-7e83-4471-918f-0ae767de7bef"></a><a name="section-6.1"></a><p></p>
<h2>General:</h2>
<p class="First">Do not touch dropper tip to any surface as this may contaminate the solution. As with all anesthetics, continuous and prolonged use should be avoided. Protection of the eye from irritating chemicals,Â foreign bodies and rubbing during the period of anesthesia is very important. Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be used cautiously in patients with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> or cardiacÂ  disease. If signs of sensitivity develop during the treatment or irritation persists or increases, patients should be advised to discontinue use and consult prescribing physician. </p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="LINK_cd1d82d7-44a1-487b-a51e-f3c975d2b381"></a><a name="section-6.2"></a><p></p>
<h2>Information
for Patients:</h2>
<p class="First">Keep this and all drugs out of the reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately. </p>
<p>After instillation of this product, the surface of the eye is insensitive and can be scratched without your feeling it. Do not rub eye. Do not instill this product repeatedly because severe eye damage may occur. </p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="LINK_ca723ce3-b676-4f30-9a69-bfd1db8c615e"></a><a name="section-6.3"></a><p></p>
<h2>Carcinogenesis,
Mutagenesis, Impairment of Fertility:</h2>
<p class="First">No studies have been conducted in animals or in humans to evaluate the potential of these effects. </p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_207bd8ad-bcea-43c5-9870-145377ba651b"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy
Category C:</h2>
<p class="First">Animal reproduction studies have not been performed with Tetracaine Hydrochloride. It is also notÂ known whether Tetracaine Hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be given to pregnant women only if clearly needed. </p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="LINK_180152ae-cd87-4ba7-ab8a-bf8516079793"></a><a name="section-6.5"></a><p></p>
<h2>Nursing
Mothers:</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted inÂ human milk, caution should be exercised when Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is administered to a nursing mother. </p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_bbe36c65-b0ca-4265-a51e-be54e569512d"></a><a name="section-6.6"></a><p></p>
<h2>Pediatric
Use:</h2>
<p class="First">Â Safety and effectiveness in children have not been established. </p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_5f337e81-6b6f-45ed-9e32-791dacabd65a"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">Transient symptoms (signs) such as <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, burning and <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival redness</span> may occur. A rare, severe, immediate type allergic corneal reaction has been reported characterized by acute diffuse epithelial <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span> with filament formation and/or <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">sloughing</span> of large areas of necrotic epithelium, diffuse stromal <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">descemetitis</span> and <span class="product-label-link" type="condition" conceptid="4274964" conceptname="Iritis">iritis</span>. </p>
<p>TO REPORT SUSPECTED ADVERSE REACTIONS, contact Altaire Pharmaceuticals, Inc., at 1-800-258-2471 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. </p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_a275449e-5000-49bf-aac1-76578e70aca8"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First"><span class="Bold">For Tonometry and Other Procedures of Short Duration:<br></span>Instill one or two drops just prior to evaluation. </p>
<p><span class="Bold">For Minor Surgical Procedures such as Foreign Body or Suture Removal:<br></span>Instill one or two drops every five to ten minutes for one to three doses. </p>
<p><span class="Bold">For Prolonged Anesthesia as in <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">Cataract</span> Extraction:<br></span>Instill one or two drops in the eye(s) every five to ten minutes for three to five doses. </p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_512add39-ea13-47d3-b1fa-576a55a48378"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is supplied in 15 mL and 30 mL single drop plastic containers. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_60572aaf-bfa2-4485-a72c-3d192a76db2a"></a><a name="section-10"></a><p></p>
<h1>STORAGE:</h1>
<p class="First">Store at room temperature, 15Â°-30Â°C (59Â°-86Â°F).</p>
<p>Keep container tightly closed. Protect from light. </p>
<p>Rev. 06/2014<br>MG #17273</p>
<p>Manufactured by: Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â Â [LOGO]<br> Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â ALTAIRE PHARMACEUTICALS, INC. <br> Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â  Â Â Â Â Aquebogue, NY 11931 USA</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_0c627751-c680-45c0-a16a-872cb56494f1"></a><a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First">NDC 59390-181-13<br>ALTACAINE<br>Tetracaine Hydrochloride <br>Ophthalmic Solution <br>USP, 0.5% STERILE<br>Rx only<br>15 mL</p>
<div class="Figure"><img alt="NDC 59390-181-13 ALTACAINE Tetracaine Hydrochloride Ophthalmic Solution USP, 0.5% STERILE Rx only 15 mL" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fd57efaa-9129-47e0-8d47-191e0adb620e&amp;name=tetracaine-hydrochloride-ophthalmic-solution-usp-0-2.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ALTACAINEÂ 		
					</strong><br><span class="contentTableReg">tetracaine hydrochloride solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:59390-181</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TETRACAINE HYDROCHLORIDE</strong> (TETRACAINE) </td>
<td class="formItem">TETRACAINE HYDROCHLORIDE</td>
<td class="formItem">5Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CHLOROBUTANOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BORIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>EDETATE DISODIUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POTASSIUM CHLORIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:59390-181-13</td>
<td class="formItem">15 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">02/01/2002</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Altaire Pharmaceuticals Inc.
							(786790378)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 6/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>50f34194-b263-4241-a61b-94d4a615a543</div>
<div>Set id: fd57efaa-9129-47e0-8d47-191e0adb620e</div>
<div>Version: 3</div>
<div>Effective Time: 20140616</div>
</div>
</div>Â <div class="DistributorName">Altaire Pharmaceuticals Inc.</div></p>
</body></html>
